Preferred Label : asciminib hydrochloride;
CAS number : C5U34S9XFV;
Origin ID : M000675720;
Currated CISMeF NLP mapping
- Related record
https://www.ema.europa.eu/en/medicines/human/EPAR/scemblix
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
asciminib
asciminib
orphan drug production
asciminib
antineoplastic agents
antineoplastic agents
leukemia, myelogenous, chronic, bcr-abl positive
Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive
administration, oral
Tyrosine Kinase Inhibitor
protein kinase inhibitors
protein kinase inhibitors
protein-tyrosine kinases
product surveillance, postmarketing
asciminib hydrochloride
asciminib hydrochloride
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Tyrosine Kinase Inhibitors
---
